Brand semaglutide
Sold by MediRX · every brand semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$399
| Medication · Homepage hero banner, "Name Brand" Ozempic tier | $399 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Homepage hero banner, "Name Brand" Ozempic tier “Name Brand Ozempic® Injection Starting at $399 Same active ingredient as Mounjaro® and Zepbound®. One simple injection per week Get started” source, read September 2, 2026 | Per month$399 | Charged today$399 |
We earn nothing from this link. MediRX has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- September 2, 2026 — $399
- September 3, 2026 — $399
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | RedRock Pharmacy, St. George UT; Health Warehouse, Florence KY; Precision Compounding Pharmacy, Bellmore NY; Triad Rx, Daphne AL |
|---|---|
| States | All 50 states |
| Cancellation | “You may cancel your monthly subscription at any time to prevent future charges. Cancellation does not refund any payment that has already been processed. Once a prescription order has been approved and processing has begun, it cannot be canceled for a refund.” |
Not yet checked: prescriber, membership and consult fee.
Recorded from medirx.org. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Site publishes three separate, mutually contradictory price sets for the same products: the homepage hero banner (semaglutide $179, tirzepatide $399), the homepage's own pricing section a few screens down (semaglutide $149, tirzepatide $199), and the /weight-loss-solutions page (semaglutide $196/mo on a 12-month plan, tirzepatide $49 on a 3-month plan). All three are recorded above rather than picking one. The 'Name Brand Ozempic® Injection' card is labeled Name Brand but its description text is copy-pasted from the tirzepatide card ('Same active ingredient as Mounjaro® and Zepbound®'), an apparent site bug; recorded as brand semaglutide based on the product name (Ozempic) rather than the mismatched description. The homepage also shows 'NEW YEAR PROMO Only $149' though today is September -- an expired promotion still on the page. The /weight-loss-solutions page additionally contains leftover template copy referencing an unrelated brand ('Rejuve') and unrelated services (testosterone therapy, ED treatment 'Mounjaro®' mislabeled as a testosterone product), suggesting reused boilerplate never fully customized for MediRX. Prescriber sync/async could not be determined with confidence: OpenLoop disclaimer says a clinician 'will meet with the individual after checkout' but the intake copy describes an asynchronous review ('Our team of licensed professionals will review your information and provide approval'), so this was left not-found rather than guessed.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.